{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:38:53Z","timestamp":1775014733721,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier","isbn-type":[{"value":"9780128170229","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.acr.2019.03.007","type":"book-chapter","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T11:15:01Z","timestamp":1555499701000},"page":"351-384","source":"Crossref","is-referenced-by-count":23,"title":["Can CpG methylation serve as surrogate markers for immune infiltration in cancer?"],"prefix":"10.1016","member":"78","reference":[{"issue":"5","key":"10.1016\/bs.acr.2019.03.007_bb0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/icb.1997.68","article-title":"The role of CD45 and CD45-associated molecules in T cell activation","volume":"75","author":"Altin","year":"1997","journal-title":"Immunology & Cell Biology"},{"key":"10.1016\/bs.acr.2019.03.007_bb0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/bs.acr.2019.01.003","article-title":"Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumors","volume":"142","author":"Bacolod","year":"2019","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/bs.acr.2019.03.007_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/bs.acr.2015.04.006","article-title":"Examination of epigenetic and other molecular factors associated with mda-9\/Syntenin dysregulation in cancer through integrated analyses of public genomic datasets","volume":"127","author":"Bacolod","year":"2015","journal-title":"Advances in Cancer Research"},{"issue":"Suppl. 4","key":"10.1016\/bs.acr.2019.03.007_bb0025","doi-asserted-by":"crossref","first-page":"S652","DOI":"10.21037\/tcr.2016.10.69","article-title":"Immune infiltration, glioma stratification, and therapeutic implications","volume":"5","author":"Bacolod","year":"2016","journal-title":"Translational Cancer Research"},{"issue":"4","key":"10.1016\/bs.acr.2019.03.007_bb0030","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2012.02.012","article-title":"The Bcl6-SMRT\/NCoR cistrome represses inflammation to attenuate atherosclerosis","volume":"15","author":"Barish","year":"2012","journal-title":"Cell Metabolism"},{"key":"10.1016\/bs.acr.2019.03.007_bb0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coi.2017.01.005","article-title":"Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challenges","volume":"45","author":"Bethmann","year":"2017","journal-title":"Current Opinion in Immunology"},{"issue":"7","key":"10.1016\/bs.acr.2019.03.007_bb9000","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nbt.3605","article-title":"Quantitative comparison of DNA methylation assays for biomarker development and clinical applications","volume":"34","author":"BLUEPRINT Consortium","year":"2016","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10.1016\/bs.acr.2019.03.007_bb0040","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1038\/s41467-018-05570-1","article-title":"Pan-cancer deconvolution of tumour composition using DNA methylation","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nature Communications"},{"issue":"6165","key":"10.1016\/bs.acr.2019.03.007_bb0045","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","article-title":"Breakthrough of the year 2013. Cancer immunotherapy","volume":"342","author":"Couzin-Frankel","year":"2013","journal-title":"Science"},{"issue":"15","key":"10.1016\/bs.acr.2019.03.007_bb0050","first-page":"3455","article-title":"Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability","volume":"58","author":"Cunningham","year":"1998","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2019.03.007_bb0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of tumor infiltrating leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"Journal for immunotherapy of Cancer"},{"issue":"3","key":"10.1016\/bs.acr.2019.03.007_bb0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"issue":"14","key":"10.1016\/bs.acr.2019.03.007_bb0065","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1158\/1078-0432.CCR-16-2026","article-title":"Alterations in the immune cell composition in premalignant breast tissue that precede breast cancer development","volume":"23","author":"Degnim","year":"2017","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/bs.acr.2019.03.007_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-016-0130-5","article-title":"A current perspective on cancer immune therapy: Step-by-step approach to constructing the magic bullet","volume":"6","author":"D'Errico","year":"2017","journal-title":"Clinical and Translational Medicine"},{"key":"10.1016\/bs.acr.2019.03.007_bb0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40364-017-0093-8","article-title":"Utility of PD-L1 immunohistochemistry assays for predicting PD-1\/PD-L1 inhibitor response","volume":"5","author":"Diggs","year":"2017","journal-title":"Biomarker Research"},{"issue":"7695","key":"10.1016\/bs.acr.2019.03.007_bb0080","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1038\/d41586-018-02483-3","article-title":"Bringing down the cost of cancer treatment","volume":"555","author":"Dolgin","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.acr.2019.03.007_bb0085","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: Impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nature Reviews Cancer"},{"issue":"12","key":"10.1016\/bs.acr.2019.03.007_bb0090","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy","volume":"17","author":"Gibney","year":"2016","journal-title":"The Lancet Oncology"},{"key":"10.1016\/bs.acr.2019.03.007_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coi.2014.01.001","article-title":"The immune contexture of primary and metastatic human tumours","volume":"27","author":"Giraldo","year":"2014","journal-title":"Current Opinion in Immunology"},{"issue":"database issue","key":"10.1016\/bs.acr.2019.03.007_bb0100","doi-asserted-by":"crossref","first-page":"D949","DOI":"10.1093\/nar\/gks1008","article-title":"The UCSC Cancer genomics browser: Update 2013","volume":"41","author":"Goldman","year":"2013","journal-title":"Nucleic Acids Research"},{"issue":"10","key":"10.1016\/bs.acr.2019.03.007_bb0105","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1221555","article-title":"Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy","volume":"5","author":"Goltz","year":"2016","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/bs.acr.2019.03.007_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","article-title":"Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: A comprehensive review of registration trials and future considerations","volume":"6","author":"Gong","year":"2018","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"1","key":"10.1016\/bs.acr.2019.03.007_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12964-016-0155-9","article-title":"Reactivation of dormant anti-tumor immunity\u2014A clinical perspective of therapeutic immune checkpoint modulation","volume":"15","author":"Greil","year":"2017","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"5","key":"10.1016\/bs.acr.2019.03.007_bb0120","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2013.05.012","article-title":"Gene expression is circular: Factors for mRNA degradation also foster mRNA synthesis","volume":"153","author":"Haimovich","year":"2013","journal-title":"Cell"},{"issue":"7528","key":"10.1016\/bs.acr.2019.03.007_bb0125","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/bs.acr.2019.03.007_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw144","article-title":"Genomic analysis of immune cell infiltrates across 11 tumor types","volume":"108","author":"Iglesia","year":"2016","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1016\/bs.acr.2019.03.007_bb0135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"issue":"8","key":"10.1016\/bs.acr.2019.03.007_bb0140","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1172\/JCI91095","article-title":"DNA methylation-based immune response signature improves patient diagnosis in multiple cancers","volume":"127","author":"Jeschke","year":"2017","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/bs.acr.2019.03.007_bb0145","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1073\/pnas.0538056100","article-title":"Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice","volume":"100","author":"Johnson","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5713","key":"10.1016\/bs.acr.2019.03.007_bb0150","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1126\/science.307.5713.1182a","article-title":"National Institutes of Health. NCI gears up for cancer genome project","volume":"307","author":"Kaiser","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.acr.2019.03.007_bb0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/107999002753452610","article-title":"Activities of IRF-1","volume":"22","author":"Kroger","year":"2002","journal-title":"Journal of Interferon & Cytokine Research"},{"issue":"4","key":"10.1016\/bs.acr.2019.03.007_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1045","article-title":"The power and the promise of DNA methylation markers","volume":"3","author":"Laird","year":"2003","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10.1016\/bs.acr.2019.03.007_bb0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: Implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biology"},{"issue":"2","key":"10.1016\/bs.acr.2019.03.007_bb0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1373\/clinchem.2007.095992","article-title":"DNA methylation biomarkers for blood-based colorectal cancer screening","volume":"54","author":"Lofton-Day","year":"2008","journal-title":"Clinical Chemistry"},{"key":"10.1016\/bs.acr.2019.03.007_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13148-017-0354-2","article-title":"Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression","volume":"9","author":"Marwitz","year":"2017","journal-title":"Clinical Epigenetics"},{"key":"10.1016\/bs.acr.2019.03.007_bb0180","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40425-016-0178-1","article-title":"Validation of biomarkers to predict response to immunotherapy in cancer: Volume I\u2014Pre-analytical and analytical validation","volume":"4","author":"Masucci","year":"2016","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/bs.acr.2019.03.007_bb0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ctrv.2018.02.005","article-title":"Breaking the biomarker code: PD-L1 expression and checkpoint inhibition in advanced NSCLC","volume":"65","author":"Melosky","year":"2018","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/bs.acr.2019.03.007_bb0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1600-065X.2003.00014.x","article-title":"Role of protein tyrosine phosphatases in T cell activation","volume":"191","author":"Mustelin","year":"2003","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.acr.2019.03.007_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fonc.2014.00197","article-title":"X-linked inhibitor of apoptosis protein\u2014A critical death resistance regulator and therapeutic target for personalized cancer therapy","volume":"4","author":"Obexer","year":"2014","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.acr.2019.03.007_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6059203","article-title":"Beyond immune cell migration: The emerging role of the Sphingosine-1-phosphate receptor S1PR4 as a modulator of innate immune cell activation","volume":"2017","author":"Olesch","year":"2017","journal-title":"Mediators of Inflammation"},{"issue":"1","key":"10.1016\/bs.acr.2019.03.007_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-017-0467-0","article-title":"DNA methylation profiles in cancer diagnosis and therapeutics","volume":"18","author":"Pan","year":"2018","journal-title":"Clinical and Experimental Medicine"},{"issue":"4","key":"10.1016\/bs.acr.2019.03.007_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004041","article-title":"HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1","volume":"10","author":"Peng","year":"2014","journal-title":"PLoS Pathogens"},{"issue":"8","key":"10.1016\/bs.acr.2019.03.007_bb0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3727\/095535491820873092","article-title":"Direct correlation between methylation status and expression of the human O-6-methylguanine DNA methyltransferase gene","volume":"3","author":"Pieper","year":"1991","journal-title":"Cancer Communications"},{"issue":"2","key":"10.1016\/bs.acr.2019.03.007_bb0220","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1742-4658.2012.08587.x","article-title":"Regulating naive and memory CD8 T cell homeostasis-a role for protein tyrosine phosphatases","volume":"280","author":"Pike","year":"2013","journal-title":"FEBS Journal"},{"issue":"15_suppl","key":"10.1016\/bs.acr.2019.03.007_bb0225","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1200\/jco.2015.33.15_suppl.3001","article-title":"Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature","volume":"33","author":"Ribas","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"6230","key":"10.1016\/bs.acr.2019.03.007_bb0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/bs.acr.2019.03.007_bb0235","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"1-2","key":"10.1016\/bs.acr.2019.03.007_bb0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/bs.acr.2019.03.007_bb0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13148-018-0512-1","article-title":"DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer","volume":"10","author":"Sasidharan Nair","year":"2018","journal-title":"Clinical Epigenetics"},{"key":"10.1016\/bs.acr.2019.03.007_bb0250","first-page":"1","article-title":"Predictive potential and need for standardization of PD-L1 immunohistochemistry","author":"Savic Prince","year":"2018","journal-title":"Virchows Archiv"},{"issue":"1","key":"10.1016\/bs.acr.2019.03.007_bb0255","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","article-title":"Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures","volume":"17","author":"Senbabaoglu","year":"2016","journal-title":"Genome Biology"},{"issue":"7","key":"10.1016\/bs.acr.2019.03.007_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179726","article-title":"Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors","volume":"12","author":"Siemers","year":"2017","journal-title":"PLoS One"},{"issue":"43","key":"10.1016\/bs.acr.2019.03.007_bb0265","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/bs.acr.2019.03.007_bb0270","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.21873\/anticanres.11144","article-title":"Cancer immunology and immunotherapy","volume":"36","author":"Sukari","year":"2016","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.acr.2019.03.007_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2017.03.012","article-title":"Mechanistic and pharmacologic insights on immune checkpoint inhibitors","volume":"120","author":"Sweis","year":"2017","journal-title":"Pharmacological Research"},{"issue":"5","key":"10.1016\/bs.acr.2019.03.007_bb0280","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/14712598.2015.1025047","article-title":"Histone deacetylation meets miRNA: Epigenetics and post-transcriptional regulation in cancer and chronic diseases","volume":"15","author":"Swierczynski","year":"2015","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"10","key":"10.1016\/bs.acr.2019.03.007_bb0285","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab","volume":"32","author":"Topalian","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1016\/bs.acr.2019.03.007_bb0290","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.160.9.4375","article-title":"Interaction of HLA-E with peptides and the peptide transporter in vitro: Implications for its function in antigen presentation","volume":"160","author":"Ulbrecht","year":"1998","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.1016\/bs.acr.2019.03.007_bb0295","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/15592294.2016.1273308","article-title":"Mutual regulation of microRNAs and DNA methylation in human cancers","volume":"12","author":"Wang","year":"2017","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/bs.acr.2019.03.007_bb0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtho.2016.08.123","article-title":"Validation of the SHOX2\/PTGER4 DNA methylation marker panel for plasma-based discrimination between patients with malignant and nonmalignant lung disease","volume":"12","author":"Weiss","year":"2017","journal-title":"Journal of Thoracic Oncology"},{"issue":"5","key":"10.1016\/bs.acr.2019.03.007_bb0305","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.pap.0000213041.39070.2f","article-title":"Diagnostic immunohistochemistry: What can go wrong?","volume":"13","author":"Yaziji","year":"2006","journal-title":"Advances in Anatomic Pathology"},{"issue":"4","key":"10.1016\/bs.acr.2019.03.007_bb0310","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nmeth0409-239","article-title":"The UCSC cancer genomics browser","volume":"6","author":"Zhu","year":"2009","journal-title":"Nature Methods"}],"container-title":["Advances in Cancer Research","Immunotherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X19300235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X19300235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:14:55Z","timestamp":1758741295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X19300235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128170229"],"references-count":62,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2019.03.007","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}